JOHN NEIS - 30 Jun 2021 Form 4 Insider Report for Cellectar Biosciences, Inc. (CLRB)

Role
Director
Signature
/s/ Christina Blakley, attorney-in-fact for John Neis
Issuer symbol
CLRB
Transactions as of
30 Jun 2021
Net transactions value
$0
Form type
4
Filing time
02 Jul 2021, 16:03:32 UTC
Next filing
01 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLRB Stock option (right to buy) Award $0 +78,000 $0.000000 78,000 30 Jun 2021 Common Stock 78,000 $1.19 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest on the first anniversary of the date of grant.